Kennaway E. 1942. A contribution of the mythology of cancer research. Lancet 2:769-772.

Kitamura K. 1954. Tumors of skin. J Dermatol and Venereal Dis 64:303-312.

Klehr NW. 1984. Late manifestations in former mustard gas workers, with special consideration of the cutaneous findings. Zeitschrift fur Hautkrankheiten 59:1161-1170. [In German]

Krause H, Grussendorf El. 1978. Syntopy of Bowen's disease and "Lost"-induced scar. Hautarzt 29:490-493. [In German]

Kravitz P, McDonald CJ. 1978. Topical nitrogen mustard-induced carcinogenesis. Acta Dermato-Venereologica 58:421-425.

Lawley P, Brookes P. 1965. Molecular mechanism of the cytotoxic action of difunctional alkylating agents and of resistance to this action. Nature 206:480-483.

Martens ME. 1991. Glucose metabolism and NAD⁺ content in cultured human epidermal keratinocytes exposed to sulfur mustard (abstract). FASEB Journal 5:A823.

Mathias CGT. 1987. Clinical and experimental aspects of cutaneous irritation. In: Marzulli FN, Maibach HI, eds. Dermatotoxicology. 3rd ed. Washington, DC: Hemisphere Publishing.

McGown EL, Van Ravenswaay T, Damlao CR. 1985. Histologic changes caused by application of Lewisite analogs to mouse skin and human skin xenografts. San Francisco: Letterman Army Institute of Research. AD-A159-554.

McGown EL, Van Ravenswaay T, Dumlao CR. 1987. Histologic changes in nude mouse skin and human skin xenografts following exposure to sulfhydryl reagents: arsenicals. Toxicologic Pathology 15:149-156.

McNamara BP, Owens EJ, Christensen MK, Vocci FJ, Ford DF, Rozimarek H. 1975. Toxicological Basis for Controlling Levels of Mustard in the Environment. Edgewood Arsenal Special Publication EB-SP-74030. Aberdeen Proving Ground, Maryland: U.S. Army Armament Command. Edgewood Arsenal Biomedical Laboratory.

Mitcheltree LW, Mershon MM, Wall HG, Pulliam JD, Manthei JH. 1989. Microblister formation in vesicant-exposed pig skin. Journal of Toxicology—Cutaneous and Ocular Toxicology 8:309-319.

Miyaji T. 1963. Skin cancer in Japan: a nationwide 5 year survey. In: Urbach F, ed. Conference on Biology of Cutaneous Cancer. National Cancer Institute Monograph No. 10. 55-70.

Momeni AZ, Enshaeih S, Meghadi M, Amindjavaheri M. 1992. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Archives of Dermatology 128:775-580.

Montgomery H, Waisman M. 1941. Epithelioma attributable to arsenic. Journal of Investigative Dermatology 4:365-383.

Nagy SM, Golumbic C, Stein WH, Fruton JS, Bergmann M. 1946. The penetration of vesicant vapors into human skin. Journal of General Physiology 29:441-469.

National Research Council. Division of Medical Sciences. 1977. Arsenic. Medical and Biologic Effects of Environmental Pollutants. Washington, DC: National Academy of Sciences.

Novick M, Gard DH, Hardy SB, Spira M. 1977. Burn scar carcinoma: a review and analysis of 46 cases. Journal of Trauma 17:809-817.

Papirmeister B, Feister AJ, Robinson SI, Ford RD. 1991. Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications. Boca Raton, FL: CRC Press.

Pershagen G. 1981. The carcinogenicity of arsenic. Environmental Health Perspectives 40:93-100.

Peters RA. 1955. Biochemistry of toxic agents: I. Present status of knowledge of biochemical lesions induced by trivalent arsenical poisoning. Bulletin of Johns Hopkins Hospital 97:1-20.

Peters RA, Sinclair HM, Thompson RHS. 1946. An analysis of the inhibition of pyruvate